Reasons why Recursion Pharmaceuticals Inc’s (NASDAQ:RXRX) fundamentals are futile
The price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares last traded on Wall Street fell -7.86% to $5.63. RXRX stock price is now -21.54% away from the 50-day moving average and -29.91% away from the 200-day moving average. The market capitalization of the company currently stands at $1.19B. With the price target of $8, Morgan Stanley […]
Do you still think Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is worth a look?
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $5.23, up 2.75% from the previous session. RXRX stock price is now -29.53% away from the 50-day moving average and -35.37% away from the 200-day moving average. The market capitalization of the company currently stands at $1.11B. With the price target of $8, […]
How should investors evaluate Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)?
Stocks of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) traded higher last session on Wall Street, down -3.32% to $8.44. According to the data, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) has 7 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and […]
Do you still think Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is worth a look?
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares traded at $8.60, unchanged from the previous session. As of this writing, 7 analysts cover Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a low […]
How Do Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)’s Fundamentals Affect Performance
The price of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares last traded on Wall Street rose 3.17% to $8.80. Based on available information, 8 analysts follow Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a low of […]
A secret that hides Recursion Pharmaceuticals Inc.’s strength (NASDAQ:RXRX)
Stocks of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) traded higher last session on Wall Street, up 3.30% to $9.38. According to the data, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) has 8 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and […]
Recursion Pharmaceuticals Inc. (RXRX) Holding Strong: What’s pushing it?
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares traded at $9.19, down -1.39% from the previous session. 8 analysts cover Recursion Pharmaceuticals Inc. (NASDAQ:RXRX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a […]
There is little time left for Recursion Pharmaceuticals Inc. (RXRX) to reach its 1-year target estimate. How soon will it surpass it?
The stock of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) last traded at $10.97, down -5.02% from the previous session. Data from the available sources indicates that Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is covered by 8 analysts. The consensus rating among analysts is ‘Overweight’. RXRX stock price is now 6.63% away from the 50-day moving average and 28.31% away […]
Do futuristic bulls still own Recursion Pharmaceuticals Inc. [RXRX] stock?
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares traded 1.68% higher at $13.63 on Wall Street last session. In accordance with the data, 8 analysts cover Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $35.00 and a low of $9.00, […]
There has been a significant shift in the fundamentals for Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)
The stock of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) last traded at $6.59, down -9.60% from the previous session. Data from the available sources indicates that Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is covered by 8 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
